HekeTiss presented its translational journey from mechanistic research to first-in-human clinical evaluation, highlighting the therapeutic potential of RGD-activated adipose-derived stromal cells in chronic wound revascularization.

Oral presentation

Title: Adipose-Derived Stromal Cells Activated by RGD Motifs Revascularize Chronic Wounds: From Research to First-in-Human Trial

Speaker: Olivier Preynat-Seauve

This presentation showcased the transition from foundational mechanistic insights to early clinical application, demonstrating the ability of RGD-activated stromal cells to promote vascularization and support healing in chronic wounds.